Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Pharmacol ; 149(4): 416-23, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16953187

RESUMO

BACKGROUND AND PURPOSE: We explored the stereoselective activation of the P2Y11 receptor, stably expressed and tagged with GFP, in 1321N1 cells, in comparison to its closest homologue, the P2Y1 receptor. EXPERIMENTAL APPROACH: The potency of several chiral ATP analogues was determined by measuring increases in intracellular calcium concentration ([Ca2+]i). In a series of ATP-alpha-B and ATP-alpha-S analogues, a non-bridging oxygen atom of Palpha was substituted by BH3 or sulphur, respectively, introducing a chiral center at Palpha. The pairs of diastereoisomers (A and B isomers) were each applied as purified compounds. KEY RESULTS: The (B) isomers (ATP-alpha-B Sp isomers and ATP-alpha-S Rp isomers) of all derivatives tested were more potent at the P2Y11 receptor than the corresponding (A) isomers (ATP-alpha-B Rp isomers and ATP-alpha-S Sp isomers) and the parent compounds. This characteristic of the P2Y11 receptor is opposite to the behaviour of the same diastereoisomers at the P2Y1 receptor, at which the (A) isomers are more active. CONCLUSIONS AND IMPLICATIONS: The distinctly opposite diastereoselective activity of ATP derivatives at the P2Y11 and the P2Y1 receptor will allow the deciphering of structural differences of the ligand recognition sites between these receptor subtypes and may aid in the development of subtype-selective agonists. Moreover, ATP-alpha-B diastereoisomers are not active at the P2Y2 receptor. Thus, they are compounds suitable for distinguishing the functional contribution of the two ATP-activated P2Y receptors, the P2Y2 and P2Y11 receptor, in physiological or pathophysiological responses of cells.


Assuntos
Trifosfato de Adenosina/análogos & derivados , Compostos de Boro/farmacologia , Agonistas do Receptor Purinérgico P2 , Trifosfato de Adenosina/química , Trifosfato de Adenosina/farmacologia , Compostos de Boro/química , Sinalização do Cálcio/efeitos dos fármacos , Linhagem Celular Tumoral , Proteínas de Fluorescência Verde/genética , Humanos , Receptores Purinérgicos P2/genética , Receptores Purinérgicos P2/metabolismo , Receptores Purinérgicos P2Y1 , Proteínas Recombinantes de Fusão/agonistas , Proteínas Recombinantes de Fusão/metabolismo , Estereoisomerismo , Relação Estrutura-Atividade , Transfecção
2.
Cell Mol Life Sci ; 62(12): 1388-99, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15924261

RESUMO

Extracellular nucleotides exert a large number of physiological effects through activation of P2Y receptors. We expressed rat P2Y2 (rP2Y2) receptor, tagged with green fluorescent protein (GFP) in HEK-293 cells and visualized receptor translocation in live cells by confocal microscopy. Functional receptor expression was confirmed by determining [Ca2+]i responses. Agonist stimulation caused a time-dependent translocation of the receptor from the plasma membrane to the cytoplasm. Rearrangement of the actin cytoskeleton was observed during agonist-mediated rP2Y2-GFP receptor internalization. Colocalization of the internalized receptor with early endosomes, clathrin and lysosomes was detected by confocal microscopy. The inhibition of receptor endocytosis by either high-density medium or chlorpromazine in the presence of UTP indicates that the receptor was internalized by the clathrin-mediated pathway. The caveolin-mediated pathway was not involved. Targeting of the receptor from endosomes to lysosomes seems to involve the proteasome pathway, because proteasomal inhibition increased receptor recycling back to the plasma membrane.


Assuntos
Actinas/metabolismo , Clatrina/metabolismo , Citoesqueleto/metabolismo , Endocitose , Proteínas de Fluorescência Verde/metabolismo , Receptores Purinérgicos P2/metabolismo , Animais , Cálcio/metabolismo , Caveolina 1 , Caveolinas/metabolismo , Membrana Celular/metabolismo , Células Cultivadas , Clorpromazina/farmacologia , Vesículas Revestidas por Clatrina/metabolismo , Citoplasma/metabolismo , Proteínas de Fluorescência Verde/genética , Humanos , Rim/metabolismo , Lisossomos/metabolismo , Inibidores de Proteassoma , Transporte Proteico , Ratos , Receptores Purinérgicos P2Y2 , Uridina Trifosfato/metabolismo
3.
Br J Pharmacol ; 142(5): 869-78, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15197109

RESUMO

P2Y-nucleotide receptors represent important targets for drug development. The lack of stable and receptor specific agonists, however, has prevented successful therapeutic applications. A novel series of P-boronated ATP derivatives (ATP-alpha-B) were synthesized by substitution of a nonbridging O at P(alpha) with a BH(3) group. This introduces a chiral center, thus resulting in diastereoisomers. In addition, at C2 of the adenine ring a further substitution was made (Cl- or methylthio-). The pairs of diastereoisomers were denoted here as A and B isomers. Here, we tested the receptor subtype specificity of these analogs on HEK 293 cells stably expressing rat P2Y(1) and rat P2Y(2) receptors, respectively, both attached to the fluorescent marker protein GFP (rP2Y(1)-GFP, rP2Y(2)-GFP). We investigated agonist-induced receptor endocytosis, [Ca(2+)](i) rise and arachidonic acid (AA) release. Agonist-induced endocytosis of rP2Y(1)-GFP was more pronounced for the A isomers than the corresponding B counterparts for all ATP-alpha-B analogs. Both 2-MeS-substituted diastereoisomers induced a greater degree of agonist-induced receptor endocytosis as compared to the 2-Cl-substituted derivatives. Endocytosis results are in accordance with the potency to induce Ca(2+) release by these compounds in HEK 293 cells stably transfected with rP2Y(1). In case of rP2Y(2)-GFP, the borano-nucleotides were very weak agonists in comparison to UTP and ATP in terms of Ca(2+) release, AA release and in inducing receptor endocytosis. The different ATP-alpha-B derivatives and also the diastereoisomers were equally ineffective. Thus, the new agonists may be considered as potent and highly specific agonist drug candidates for P2Y(1) receptors. The difference in activity of the ATP analogs at P2Y receptors could be used as a tool to investigate structural differences between P2Y receptor subtypes.


Assuntos
Trifosfato de Adenosina/análogos & derivados , Agonistas do Receptor Purinérgico P2 , Ácido Araquidônico/metabolismo , Cálcio/metabolismo , Linhagem Celular , DNA Complementar/biossíntese , DNA Complementar/genética , Endocitose/efeitos dos fármacos , Proteínas de Fluorescência Verde/metabolismo , Humanos , Marcação por Isótopo , Microscopia Confocal , Conformação Molecular , Receptores Purinérgicos P2Y1 , Receptores Purinérgicos P2Y2 , Proteínas Recombinantes/metabolismo , Estereoisomerismo , Relação Estrutura-Atividade , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...